Solubilisation capacity of Brij surfactants.
Maria E N P Ribeiro, Carolina L de Moura, Mariano G S Vieira, Nilce V Gramosa, Chiraphon Chaibundit, Marcos C de Mattos, David Attwood, Stephen G Yeates, S Keith Nixon, Nágila M P S Ricardo
Index: Int. J. Pharm. 436(1-2) , 631-5, (2012)
Full Text: HTML
Abstract
The aim of this study was to investigate the potential of selected Brij non-ionic surfactants for enhancing the solubility of poorly water-soluble drugs. Griseofulvin was selected as a model drug candidate enabling comparisons to be made with the solubilisation capacities of other poly(ethylene oxide)-based copolymers. UV/Vis and (1)H NMR spectroscopies were used to quantify the enhancement of solubility of griseofulvin in 1 wt% aqueous micellar solutions of Brij 78 (C(18)H(37)E(20)), Brij 98 (C(18)H(35)E(20)) and Brij 700 (C(18)H(37)E(100)) (where E represents the OCH(2)CH(2) unit of the poly(ethylene oxide) chain) at 25, 37 and 40 °C. Solubilisation capacities (S(cp) expressed as mg griseofulvin per g Brij) were similar for Brij 78 and 98 (range 6-11 mg g(-1)) but lower for Brij 700 (3-4 mg g(-1)) as would be expected for the surfactant with the higher ethylene oxide content. The drug loading capacity of micelles of Brij 78 was higher than many di- and triblock copolymers with hydrophilic E-blocks specifically designed for enhancement of drug solubility.Copyright © 2012 Elsevier B.V. All rights reserved.
Related Compounds
Related Articles:
Tailored microcrystal growth: a facile solution-phase synthesis of gold rings.
2011-10-11
[Adv. Mater. 23(38) , 4431-4, (2011)]
1997-11-01
[J. Clin. Microbiol. 35(11) , 2791-4, (1997)]
Intranasal administration of plasmid DNA-coated nanoparticles results in enhanced immune responses.
2002-09-01
[J. Pharm. Pharmacol. 54(9) , 1195-203, (2002)]
2003-02-01
[J. Ocul. Pharmacol. Ther. 19(1) , 11-21, (2003)]
Tresyl-based conjugation of protein antigen to lipid nanoparticles increases antigen immunogenicity
2010-01-01
[Int. J. Pharm. 401(1-2) , 87-92, (2010)]